Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-23

FDA Approved: CAFFEINE CITRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for caffeine citrate from Hikma Pharmaceuticals USA Inc., resulting in labeling changes to the existing NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caffeine citrate (caffeine citrate)

Snippet

SUPPL AP for CAFFEINE CITRATE (CAFFEINE CITRATE)